Diagnostic Performance of Serum Soluble HLA-G for Lung Cancer: A Case–Control Study
Open Access
- 14 October 2026
- journal article
- Published by Hitit University in Hitit Medical Journal
- Vol. 8 (3) , 476-485
Abstract
Objective: Human leukocyte antigen G (HLA-G) is a nonclassical class I molecule with immunosuppressive properties that may facilitate tumor immune escape. Elevated circulating soluble HLA-G (sHLA-G) levels have been reported in several malignancies. This study aimed to evaluate the diagnostic performance of serum sHLA-G levels in patients with lung cancer and to investigate whether smoking status influences these levels.Materials and Methods: This case–control study included 62 patients with newly diagnosed lung cancer, 40 smoker controls, and 31 nonsmoker healthy controls. Serum sHLA-G levels were measured using an enzyme-linked immunosorbent assay (ELISA). Statistical comparisons among groups were performed using one-way analysis of variance and correlation analyses. Receiver operating characteristic (ROC) curve analysis was conducted to assess the diagnostic performance of sHLA-G.Results: Mean serum sHLA-G levels were significantly higher in patients with lung cancer than in nonsmoker controls (16.14 ± 8.71 U/mL vs 10.21 ± 4.77 U/mL, p=0.04). When smoker and nonsmoker controls were combined, the difference remained significant (pKeywords
Funding Information
- Düzce University (2012.04.HD.040)
This publication has 17 references indexed in Scilit:
- Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCANCancer Epidemiology, 2024
- Description of an activity-based enzyme biosensor for lung cancer detectionCommunications Medicine, 2024
- Soluble HLA-G (sHLA-G) measurement might be useful as an early diagnostic biomarker and screening test for gastric cancerScientific Reports, 2023
- HLA-G5 in the blood of leukemia patients and healthy individualsLeukemia Research, 2013
- Plasma soluble HLA‐G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancerTissue Antigens, 2011
- Prognostic relevance of soluble human leukocyte antigen–G and total human leukocyte antigen class I molecules in lung cancer patientsHuman Immunology, 2010
- Clinical relevance and functional implications for human leucocyte antigen‐g expression in non‐small‐cell lung cancerJournal of Cellular and Molecular Medicine, 2009
- Beyond the increasing complexity of the immunomodulatory HLA-G moleculeBlood, 2008
- Human Leukocyte Antigen–G and Cancer ImmunoeditingCancer Research, 2008
- HLA-G Proteins in Cancer: Do They Provide Tumor Cells with an Escape Mechanism?Cancer Research, 2005